APO Research
Talk to an analyst

APO RESEARCH · REPORT

Laboratory Developed Tests (LDT)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Laboratory Developed Tests (LDT) Market Outlook and Growth Opportunities 2026

15 January 2026192 pages

Choose your research edition.

Industry ResearchLaboratory Developed Tests (LDT) Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Laboratory Developed Tests (LDT) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Laboratory Developed Tests (LDT) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Laboratory Developed Tests (LDT) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Laboratory Developed Tests (LDT) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Laboratory Developed Tests (LDT) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Laboratory Developed Tests (LDT) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Laboratory Developed Tests (LDT) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Laboratory Developed Tests (LDT) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Laboratory Developed Tests (LDT) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Laboratory Developed Tests (LDT) market include Quest Diagnostics, Thermo Fisher, Waters Corporation, Roche, Illumina, Qiagen, Eurofins, Guardant Health and Adaptive Biotechnologies, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Laboratory Developed Tests (LDT) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Laboratory Developed Tests (LDT) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Laboratory Developed Tests (LDT) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Laboratory Developed Tests (LDT) market.

Laboratory Developed Tests (LDT) Segment by Company

Quest Diagnostics

Thermo Fisher

Waters Corporation

Roche

Illumina

Qiagen

Eurofins

Guardant Health

Adaptive Biotechnologies

Biodesix

Berry Oncology

Genetron Health

Laboratory Developed Tests (LDT) Segment by Type

Clinical Biochemistry

Hematology

Immunology

Molecular Diagnostics

Other

Laboratory Developed Tests (LDT) Segment by Application

Hospitals Laboratory

Clinical Research Organizations

Academic Institutes

Specialty Diagnostic Centers

Other

Laboratory Developed Tests (LDT) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Laboratory Developed Tests (LDT) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Laboratory Developed Tests (LDT) key companies, revenue, market share, and recent developments.

3. To split the Laboratory Developed Tests (LDT) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Laboratory Developed Tests (LDT) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Laboratory Developed Tests (LDT) significant trends, drivers, influence factors in global and regions.

6. To analyze Laboratory Developed Tests (LDT) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laboratory Developed Tests (LDT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Laboratory Developed Tests (LDT) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laboratory Developed Tests (LDT).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Laboratory Developed Tests (LDT) industry.

Chapter 3: Detailed analysis of Laboratory Developed Tests (LDT) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Laboratory Developed Tests (LDT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Laboratory Developed Tests (LDT) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Laboratory Developed Tests (LDT) Industry Trends Table 2. Laboratory Developed Tests (LDT) Industry Drivers Table 3. Laboratory Developed Tests (LDT) Industry Opportunities and Challenges Table 4. Laboratory Developed Tests (LDT) Industry Restraints Table 5. Global Laboratory Developed Tests (LDT) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Laboratory Developed Tests (LDT) Revenue Share by Company (2021-2026) Table 7. Global Laboratory Developed Tests (LDT) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Laboratory Developed Tests (LDT) Key Company Manufacturing Base & Headquarters Table 9. Global Laboratory Developed Tests (LDT) Company, Product Type & Application Table 10. Global Laboratory Developed Tests (LDT) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Laboratory Developed Tests (LDT) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Clinical Biochemistry Table 15. Significant Companies of Hematology Table 16. Significant Companies of Immunology Table 17. Significant Companies of Molecular Diagnostics Table 18. Significant Companies of Other Table 19. Global Laboratory Developed Tests (LDT) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Laboratory Developed Tests (LDT) Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Laboratory Developed Tests (LDT) Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Laboratory Developed Tests (LDT) Sales Value Share by Type (2021-2026) Table 23. Global Laboratory Developed Tests (LDT) Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospitals Laboratory Table 25. Significant Companies of Clinical Research Organizations Table 26. Significant Companies of Academic Institutes Table 27. Significant Companies of Specialty Diagnostic Centers Table 28. Significant Companies of Other Table 29. Global Laboratory Developed Tests (LDT) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Laboratory Developed Tests (LDT) Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Laboratory Developed Tests (LDT) Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Laboratory Developed Tests (LDT) Sales Value Share by Application (2021-2026) Table 33. Global Laboratory Developed Tests (LDT) Sales Value Share by Application (2027-2032) Table 34. Global Laboratory Developed Tests (LDT) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Laboratory Developed Tests (LDT) Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Laboratory Developed Tests (LDT) Sales Value Share by Region (2021-2026) Table 37. Global Laboratory Developed Tests (LDT) Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Laboratory Developed Tests (LDT) Sales Value Share by Region (2027-2032) Table 39. Global Laboratory Developed Tests (LDT) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Laboratory Developed Tests (LDT) Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Laboratory Developed Tests (LDT) Sales Value Market Share by Country (2021-2026) Table 42. Global Laboratory Developed Tests (LDT) Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Laboratory Developed Tests (LDT) Sales Value Market Share by Country (2027-2032) Table 44. Quest Diagnostics Company Information Table 45. Quest Diagnostics Business Overview Table 46. Quest Diagnostics Laboratory Developed Tests (LDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Quest Diagnostics Laboratory Developed Tests (LDT) Product Portfolio Table 48. Quest Diagnostics Recent Development Table 49. Thermo Fisher Company Information Table 50. Thermo Fisher Business Overview Table 51. Thermo Fisher Laboratory Developed Tests (LDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Thermo Fisher Laboratory Developed Tests (LDT) Product Portfolio Table 53. Thermo Fisher Recent Development Table 54. Waters Corporation Company Information Table 55. Waters Corporation Business Overview Table 56. Waters Corporation Laboratory Developed Tests (LDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Waters Corporation Laboratory Developed Tests (LDT) Product Portfolio Table 58. Waters Corporation Recent Development Table 59. Roche Company Information Table 60. Roche Business Overview Table 61. Roche Laboratory Developed Tests (LDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Roche Laboratory Developed Tests (LDT) Product Portfolio Table 63. Roche Recent Development Table 64. Illumina Company Information Table 65. Illumina Business Overview Table 66. Illumina Laboratory Developed Tests (LDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Illumina Laboratory Developed Tests (LDT) Product Portfolio Table 68. Illumina Recent Development Table 69. Qiagen Company Information Table 70. Qiagen Business Overview Table 71. Qiagen Laboratory Developed Tests (LDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Qiagen Laboratory Developed Tests (LDT) Product Portfolio Table 73. Qiagen Recent Development Table 74. Eurofins Company Information Table 75. Eurofins Business Overview Table 76. Eurofins Laboratory Developed Tests (LDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Eurofins Laboratory Developed Tests (LDT) Product Portfolio Table 78. Eurofins Recent Development Table 79. Guardant Health Company Information Table 80. Guardant Health Business Overview Table 81. Guardant Health Laboratory Developed Tests (LDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Guardant Health Laboratory Developed Tests (LDT) Product Portfolio Table 83. Guardant Health Recent Development Table 84. Adaptive Biotechnologies Company Information Table 85. Adaptive Biotechnologies Business Overview Table 86. Adaptive Biotechnologies Laboratory Developed Tests (LDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Adaptive Biotechnologies Laboratory Developed Tests (LDT) Product Portfolio Table 88. Adaptive Biotechnologies Recent Development Table 89. Biodesix Company Information Table 90. Biodesix Business Overview Table 91. Biodesix Laboratory Developed Tests (LDT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Biodesix Laboratory Developed Tests (LDT) Product Portfolio Table 93. Biodesix Recent Development Table 94. Berry Oncology Company Information Table 95. Berry Oncology Business Overview Table 96. Berry Oncology Laboratory Developed Tests (LDT) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Berry Oncology Laboratory Developed Tests (LDT) Product Portfolio Table 98. Berry Oncology Recent Development Table 99. Genetron Health Company Information Table 100. Genetron Health Business Overview Table 101. Genetron Health Laboratory Developed Tests (LDT) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Genetron Health Laboratory Developed Tests (LDT) Product Portfolio Table 103. Genetron Health Recent Development Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Laboratory Developed Tests (LDT) Product Image Figure 2. Global Laboratory Developed Tests (LDT) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Laboratory Developed Tests (LDT) Market Size (2021-2032) & (US$ Million) Figure 4. Global Laboratory Developed Tests (LDT) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Clinical Biochemistry Image Figure 8. Hematology Image Figure 9. Immunology Image Figure 10. Molecular Diagnostics Image Figure 11. Other Image Figure 12. Global Laboratory Developed Tests (LDT) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Laboratory Developed Tests (LDT) Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Laboratory Developed Tests (LDT) Sales Value Share by Type (2021-2032) Figure 15. Hospitals Laboratory Image Figure 16. Clinical Research Organizations Image Figure 17. Academic Institutes Image Figure 18. Specialty Diagnostic Centers Image Figure 19. Other Image Figure 20. Global Laboratory Developed Tests (LDT) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Laboratory Developed Tests (LDT) Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Laboratory Developed Tests (LDT) Sales Value Share by Application (2021-2032) Figure 23. Global Laboratory Developed Tests (LDT) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Laboratory Developed Tests (LDT) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Laboratory Developed Tests (LDT) Sales Value (2021-2032) & (US$ Million) Figure 26. North America Laboratory Developed Tests (LDT) Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Laboratory Developed Tests (LDT) Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Laboratory Developed Tests (LDT) Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Laboratory Developed Tests (LDT) Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Laboratory Developed Tests (LDT) Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Laboratory Developed Tests (LDT) Sales Value (2021-2032) & (US$ Million) Figure 32. South America Laboratory Developed Tests (LDT) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Laboratory Developed Tests (LDT) Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Laboratory Developed Tests (LDT) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Clinical Biochemistry
  • Hematology
  • Immunology
  • Molecular Diagnostics
  • Other
Applications
  • Hospitals Laboratory
  • Clinical Research Organizations
  • Academic Institutes
  • Specialty Diagnostic Centers
  • Other
Companies covered
  • Quest Diagnostics
  • Thermo Fisher
  • Waters Corporation
  • Roche
  • Illumina
  • Qiagen
  • Eurofins
  • Guardant Health
  • Adaptive Biotechnologies
  • Biodesix
  • Berry Oncology
  • Genetron Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Laboratory Developed Tests (LDT) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Laboratory Developed Tests (LDT) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Laboratory Developed Tests (LDT) Market Dynamics
  1. 2.1 Laboratory Developed Tests (LDT) Industry Trends
  2. 2.2 Laboratory Developed Tests (LDT) Industry Drivers
  3. 2.3 Laboratory Developed Tests (LDT) Industry Opportunities and Challenges
  4. 2.4 Laboratory Developed Tests (LDT) Industry Restraints
3 Laboratory Developed Tests (LDT) Market by Company
  1. 3.1 Global Laboratory Developed Tests (LDT) Company Revenue Ranking in 2025
  2. 3.2 Global Laboratory Developed Tests (LDT) Revenue by Company (2021-2026)
  3. 3.3 Global Laboratory Developed Tests (LDT) Company Ranking (2024-2026)
  4. 3.4 Global Laboratory Developed Tests (LDT) Company Manufacturing Base and Headquarters
  5. 3.5 Global Laboratory Developed Tests (LDT) Company Product Type and Application
  6. 3.6 Global Laboratory Developed Tests (LDT) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Laboratory Developed Tests (LDT) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Laboratory Developed Tests (LDT) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Laboratory Developed Tests (LDT) Market by Type
  1. 4.1 Laboratory Developed Tests (LDT) Type Introduction
  2. 4.1.1 Clinical Biochemistry
  3. 4.1.2 Hematology
  4. 4.1.3 Immunology
  5. 4.1.4 Molecular Diagnostics
  6. 4.1.5 Other
  7. 4.2 Global Laboratory Developed Tests (LDT) Sales Value by Type
  8. 4.2.1 Global Laboratory Developed Tests (LDT) Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Laboratory Developed Tests (LDT) Sales Value by Type (2021-2032)
  10. 4.2.3 Global Laboratory Developed Tests (LDT) Sales Value Share by Type (2021-2032)
5 Laboratory Developed Tests (LDT) Market by Application
  1. 5.1 Laboratory Developed Tests (LDT) Application Introduction
  2. 5.1.1 Hospitals Laboratory
  3. 5.1.2 Clinical Research Organizations
  4. 5.1.3 Academic Institutes
  5. 5.1.4 Specialty Diagnostic Centers
  6. 5.1.5 Other
  7. 5.2 Global Laboratory Developed Tests (LDT) Sales Value by Application
  8. 5.2.1 Global Laboratory Developed Tests (LDT) Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Laboratory Developed Tests (LDT) Sales Value by Application (2021-2032)
  10. 5.2.3 Global Laboratory Developed Tests (LDT) Sales Value Share by Application (2021-2032)
6 Laboratory Developed Tests (LDT) Regional Value Analysis
  1. 6.1 Global Laboratory Developed Tests (LDT) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Laboratory Developed Tests (LDT) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Laboratory Developed Tests (LDT) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Laboratory Developed Tests (LDT) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Laboratory Developed Tests (LDT) Sales Value (2021-2032)
  7. 6.3.2 North America Laboratory Developed Tests (LDT) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Laboratory Developed Tests (LDT) Sales Value (2021-2032)
  10. 6.4.2 Europe Laboratory Developed Tests (LDT) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Laboratory Developed Tests (LDT) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Laboratory Developed Tests (LDT) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Laboratory Developed Tests (LDT) Sales Value (2021-2032)
  16. 6.6.2 South America Laboratory Developed Tests (LDT) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Laboratory Developed Tests (LDT) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Laboratory Developed Tests (LDT) Sales Value Share by Country, 2025 VS 2032
7 Laboratory Developed Tests (LDT) Country-level Value Analysis
  1. 7.1 Global Laboratory Developed Tests (LDT) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Laboratory Developed Tests (LDT) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Laboratory Developed Tests (LDT) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Laboratory Developed Tests (LDT) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Laboratory Developed Tests (LDT) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Laboratory Developed Tests (LDT) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Laboratory Developed Tests (LDT) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Quest Diagnostics
  2. 8.1.1 Quest Diagnostics Company Information
  3. 8.1.2 Quest Diagnostics Business Overview
  4. 8.1.3 Quest Diagnostics Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Quest Diagnostics Laboratory Developed Tests (LDT) Product Portfolio
  6. 8.1.5 Quest Diagnostics Recent Developments
  7. 8.2 Thermo Fisher
  8. 8.2.1 Thermo Fisher Company Information
  9. 8.2.2 Thermo Fisher Business Overview
  10. 8.2.3 Thermo Fisher Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Laboratory Developed Tests (LDT) Product Portfolio
  12. 8.2.5 Thermo Fisher Recent Developments
  13. 8.3 Waters Corporation
  14. 8.3.1 Waters Corporation Company Information
  15. 8.3.2 Waters Corporation Business Overview
  16. 8.3.3 Waters Corporation Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Waters Corporation Laboratory Developed Tests (LDT) Product Portfolio
  18. 8.3.5 Waters Corporation Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Laboratory Developed Tests (LDT) Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Illumina
  26. 8.5.1 Illumina Company Information
  27. 8.5.2 Illumina Business Overview
  28. 8.5.3 Illumina Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Illumina Laboratory Developed Tests (LDT) Product Portfolio
  30. 8.5.5 Illumina Recent Developments
  31. 8.6 Qiagen
  32. 8.6.1 Qiagen Company Information
  33. 8.6.2 Qiagen Business Overview
  34. 8.6.3 Qiagen Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Qiagen Laboratory Developed Tests (LDT) Product Portfolio
  36. 8.6.5 Qiagen Recent Developments
  37. 8.7 Eurofins
  38. 8.7.1 Eurofins Company Information
  39. 8.7.2 Eurofins Business Overview
  40. 8.7.3 Eurofins Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eurofins Laboratory Developed Tests (LDT) Product Portfolio
  42. 8.7.5 Eurofins Recent Developments
  43. 8.8 Guardant Health
  44. 8.8.1 Guardant Health Company Information
  45. 8.8.2 Guardant Health Business Overview
  46. 8.8.3 Guardant Health Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Guardant Health Laboratory Developed Tests (LDT) Product Portfolio
  48. 8.8.5 Guardant Health Recent Developments
  49. 8.9 Adaptive Biotechnologies
  50. 8.9.1 Adaptive Biotechnologies Company Information
  51. 8.9.2 Adaptive Biotechnologies Business Overview
  52. 8.9.3 Adaptive Biotechnologies Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Adaptive Biotechnologies Laboratory Developed Tests (LDT) Product Portfolio
  54. 8.9.5 Adaptive Biotechnologies Recent Developments
  55. 8.10 Biodesix
  56. 8.10.1 Biodesix Company Information
  57. 8.10.2 Biodesix Business Overview
  58. 8.10.3 Biodesix Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Biodesix Laboratory Developed Tests (LDT) Product Portfolio
  60. 8.10.5 Biodesix Recent Developments
  61. 8.11 Berry Oncology
  62. 8.11.1 Berry Oncology Company Information
  63. 8.11.2 Berry Oncology Business Overview
  64. 8.11.3 Berry Oncology Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Berry Oncology Laboratory Developed Tests (LDT) Product Portfolio
  66. 8.11.5 Berry Oncology Recent Developments
  67. 8.12 Genetron Health
  68. 8.12.1 Genetron Health Company Information
  69. 8.12.2 Genetron Health Business Overview
  70. 8.12.3 Genetron Health Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Genetron Health Laboratory Developed Tests (LDT) Product Portfolio
  72. 8.12.5 Genetron Health Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst